EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 57.30
+0.30 (0.53%)
At close: Apr 2, 2026
EirGenix Market Cap
EirGenix has a market cap or net worth of 17.34 billion as of April 2, 2026. Its market cap has decreased by -24.90% in one year.
Market Cap
17.34B
Enterprise Value
15.52B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
57.30
Market Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 17.34B, an increase of 280.50%. That is a compound annual growth rate of 15.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 17.34B | -7.12% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 30.73B |
| Oneness Biotech | 25.45B |
| Lumosa Therapeutics | 24.87B |
| Sunmax Biotechnology | 21.08B |
| Medigen Vaccine Biologics | 19.30B |
| Polaris Group | 17.46B |
| AP Biosciences | 17.33B |
| TaiMed Biologics | 14.02B |